The Baidu Ventures-backed clinical research software provider received $23.2m in the round, which will fund further work on its core platform.

Precision Scientific, a China-based medical research software provider that counts internet group Baidu as an investor, has raised RMB150m ($23.2m) in series B financing, DealStreetAsia reported yesterday, citing a WeChat post.

Suzhou Kington Capital and GTJA Investment Group co-led the round, which included Polaris Capital, Grand Mount Capital, Sinovation Ventures and Maison Capital.

Precision Scientific is the creator of a software platform which applies artificial intelligence to drug research practices such as biomarker development and differentiation as well as the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn